Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED)

NCT00092833 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia, Familial
Lipid Metabolism, Inborn Errors

Interventions

DRUG: Comparator: ezetimibe

Sponsor

Organon and Co